Semicarbazone-a versatile therapeutic pharmacophore for fragment based anticonvulsant drug design

Acta Pharmaceutica

Volumn 62, Issue 3, 2012, Pages 263-286

  Pandeya, Surendra Nath ^a  

^a Saroj Institute of Technology and Management   (India)

Author keywords

Anticonvulsant; Semicarbazone

Indexed keywords

4 (4 FLUROPHENOXY)BENZALDEHYDE SEMICARBAZONE; AMIDE; ANTICONVULSIVE AGENT; BICCULINE; CARBAMAZEPINE; HYDRAZONE DERIVATIVE; N (4 BROMOPHENYL)ACETOPHENONE SEMICARBAZONE; PENTETRAZOLE; PHENYTOIN; PICROTOXIN; SEMICARBAZONE DERIVATIVE; STRYCHNINE; UNCLASSIFIED DRUG; UREA DERIVATIVE; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; ARTICLE; DRUG SCREENING; ELECTRIC SHOCK; HUMAN; MAXIMAL ELECTROSHOCK; NONHUMAN; PHARMACOPHORE;

EID: 84876567037     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-012-0030-1     Document Type: Article

References (92)

1. M. Meonardi and T. Ustun, The global burden of epilepsy, Epilepsia 43 (2002) 21-25; DOI: 10. 1046/j.1528-1157.43.s.6.11.x. (Pubitemid 35006463)
2. R. Sridharan and B. N. Murthy, Relevance and pattern of epilepsy in India, Epilepsia 40 (1999) 631-636; DOI: 10.1111/j.1528-1157.1999.tb05566x.
3. G. F. Carl and M. L. Smith, Phenytoin-folate interaction differing effect of the sodium salt and the free acid of phenytoin, Epilepsia 33 (1992) 372-375; DOI: 10.1111/j.1528-1157.1992tb02330x.
4. P. Kwan and M. J. Brodie, Phenobarbital for the treatment of epilepsy in the 21st century, a critical review, Epilepsia 45 (2004) 1141-1149; DOI: 10.1111/j.0013-9580.2004.12704.x. (Pubitemid 39238126)
5. S. D. Shorvon, Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009, Epilepsia 50 (suppl. 3) (2009) 93-130; DOI: 10.1111/j.1528-1167.2009.02042.x.
6. A. C. Foster and J. A. Kemp, Glutamate and GABA-based CNS therapeutics, Curr. Opin. Pharmacol. 6 (2006) 7-17.
7. M. Mazza, G. Della Marcla and M. DiNicola, Oxacarbazepine improves mood in the patients with epilepsy, Epilepsy Behav. 10 (2007) 397-401; DOI: 10.1016/j.yebeh.2007.01.003. (Pubitemid 46567766)
8. J. M. Rho, S. D. Donevan and M. A. Rogawaski, Barbiturate like action of the propanediol dicarbamate felbamate and meprobamate, J. Pharmacol. Exp. Ther. 280 (1997) 1383-1391. (Pubitemid 27166737)
9. C. Salome, E. Salome-Grosjean, J. P. Stables and H. Kohn, Merging the structural motifs of functionalized amino acids and alpha amino amides: compounds with significant anticonvulsant activities, J. Med. Chem. 53 (2010) 3756-3771; DOI: 10.1021/jm 100185c.
10. A. C. Errington, L. Coyne, T. Stohr, N. Selve and G. Lees, Seeking a mechanism of action for the novel anticonvulsant lacosamide, Neuropharmacology 50 (2006) 1016-1024; DOI: 10.1016/j.neuropharm. 2006.02002.
11. R. G. Fariello, Safinamide, Neurotherapeutics 4 (2007) 110-116; DOI: 10.1016/j.nurt.2006.11.011. (Pubitemid 46127463)
12. N. D. Eddington, D. S. Cox, R. R. Roberts, J. P. Stables, C. B. Powells and K. R. Scott, Enaminones-versatile therapeutic pharmacophores, Further advances, Curr. Med. Chem. 4 (2000) 417-436.
13. S. N. Pandeya and J. R. Dimmock, Recent evaluation of thiosemicarbazones and semicarbazones and related compounds for antineoplastic and anticonvulsant activities, Pharmazie 48 (1993) 659-666. (Pubitemid 23311081)
14. H. Beraldo and D. Gambino, The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes, Mini Rev. Med. Chem. 4 (2004) 31-39.
15. L. Liu, T. Zeng, M. J. Morris, C. Wallengren, A. L. Clarke, C. A. Reid, S. Petrou and T. J. O'Brien, The mechanism of carbamazepine aggravated of absence seizures, J. Pharmacol. Expt. Ther. 319 (2006) 790-798; DOI: 10.1124/jpet.106.10496.
16. S. N. Ghalmi, D. A. Berv, J. Klugman, K. J. Rosenquist and D. J. Hsu, Oxacarbazepine. Treatment of bipolar disorder, J. Clin. Psychiatry 64 (2003) 943-945; DOI: 10.4088/JCP.v64n0813.
17. C. Dulsat, N. Mealy, R. Castaner and J. Bolos, Eslicarbazepine acetate. Drugs Fut. 34 (2009) 189-199; DOI: 10.1358/dof.2009.034.03.1352675.
18. D. Schmidt and K. Utech, Progabide for refractory partial epilepsy: A controlled add-on trial, Neurology 36 (1986) 217-221. (Pubitemid 16124212)
19. S. C. Vashishtha, G. A. Zello, K. H. Nienaber, J. Balzarini, E. D. Clercq, J. P. Stables and J. R. Dimmock, Cytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compounds, Eur. J. Med. Chem. 39 (2004) 27-35. (Pubitemid 38251210)
20. S. K. Sridhar, S. N. Pandeya, J. P. Stables and A. Ramesh, Anticonvulsant activity of hydrazones, Schiff and Mannich bases of isatin derivatives, Eur. J. Pharm. Sci. 16 (2002) 129-132.
21. F. D. Popp, Potential anticonvulsants, VII Some hydrazones of indole-3-carboxaldehyde, J. Het. Chem. 21 (1984) 617-619.
22. J. Jain, Y. Kumar, R. Sinha, R. Kumar and J. Stables, Menthone aryl acid hydrazones: A new class of anticonvulsants, Med. Chem. 7 (2011) 56-61.
23. J. O. McNamara, Drugs Effective in the Therapy of Epilepsy, in Goodman and Gilman's Pharmaceutical Basis of Therapeutics (Ed. J. G. Hardman, L. E. Limbird, P. B. Molinoaff and R. W. Ruddon), 9th ed., McGraw Hill, New York 2001, pp. 461-486.
24. S. Coker, The use of phenacemide for intractable partial complex epilepsy in children, Pediatr. Neurol. 2 (1986) 230-232; DOI: 10.1016/0887-8994(86) 90053-6. (Pubitemid 17031244)
25. T. R. Browne, Fosphenytoin (cerebyx), Clin. Neuropharm. 20 (1997) 1-12; DOI: 10.1097/00002826-199702000-00001. (Pubitemid 27098350)
26. P. N. Patsalos, Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies, Epilepsia 46 (S9) (2005) 140-144; DOI: 10.1111/j.1528-1167.2005.00326.x.
27. R. Kaliviainen, K. Eriksson and I. Parviainan, Refractory generalized convulsive status epileptics: a guide to treatment, CNS Drugs 19 (2005) 759-768; DOI: 10.2165/00023210-200519090-00003. (Pubitemid 41324063)
28. J. R. Dimmock, R. N. Pathucode, J. Tuchck and G. B. Baker, Anticonvulsant activities of 4-(4'-fluorophenyl) benzaldehyde semicarbazones, Drug Dev. Res. 46 (1999) 112-125. (Pubitemid 29207270)
29. Y. Wang, S. X. Cai and J. F. W. Keanaan, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 638, 947, 28 Oct 2003.
30. J. R. Dimmock, Semicarbazones having CNS activity and pharmaceutical preparations containing same, U.S. Pat. 5, 741, 818, 21 Apr. 1998.
31. Y. Wang, S. X. Cai, N. C. Lam, J. F. W. Keanan, VI Ilynin and E Weber, Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof, U.S. Pat. 6, 613, 803, 2 Sept 2003.
32. S. X. Cai, N. C. Lam and S. Hongbal, Substituted semicarbazides and the use thereof, U. S. Pat. 6, 281, 211, 28 Aug 2001.
33. S. N. Pandeya, V. Mishra, P. N. Singh and D. C. Rupainwar, Anticonvulsant activity of thiouriedo derivatives of acetophenone semicarbazone, Pharmacol. Res. 37 (1998) 17-22. (Pubitemid 28068676)
34. V. I. Ilynin, J. D. Ponionis, G. T. Whiteside, J. E. Harrison, M. S. Meason, L. Mork, P. E. Turdin, S. Cooh, R. B. Caster, P. Nguyen, D. S. Hogencamp, S. Olanreqwajn, E. Benzamin and R. N. Woodward, Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy) phenyl]-pyrimidine-4-carboxamide (PPPA): A Potent, broad spectrum state dependent sodium channel blocker for treating painstates, J. Pharmacol. Exp. Ther. 318 (2006) 1086-1093.
35. J. R. Dimmock, R. N. Puthucode, M. S. Lo, J. W. Quail, J. Yang and J. P. Stables, Structural modification of the primary amino group of anticonvulsant aryl semicarbazones, Pharmazie 51 (1996) 83-88. (Pubitemid 26076957)
36. S. N. Pandeya, N. Aggarwal and J. S. Jain, Evaluation of semicarbazones for anticonvulsant and sedative hypnotic properties, Pharmazie 54 (1999) 300-312.
37. S. N. Pandeya, V. Mishra, I. Ponnilavarsan and J. P. Stables, Anticonvulsant activity of p-chlorophenyl substituted arylsemicarbazones-the role of primary terminal amino group, Pol. J. Pharmacol. 52 (2000) 283-290.
38. S. N. Pandeya, P. Yogeeswari and J. P. Stables, Synthesis and anticonvulsant activity of 4-bromophenyl substituted arylsemicarbazones, Eur. J. Med Chem. 35 (2000) 879-886.
39. P. Yogeeswari, J. V. Raghvendran, R. Thirumurugan, S. Induja, D. Sriram and J. P. Stables, Synthesis and structure activity relationship on anticonvulsant arylsemicarbazones, Med. Chem. 2 (2006) 55-62. (Pubitemid 44083166)
40. J. Jain, Y. Kumar, J. P. Stables and R. Sinha, Menthone semicarbazides and thiosemicarbazides as anticonvulsant agents, Med. Chem. 6 (2010) 44-50.
41. K. Verma, S. N. Pandeya, V. K. Singh, S. Gupta, P. Prashant, Anurag and G. Bhardwaj, Synthesis and pharmacolgical activity of some substituted menthone semicarbazones and thiosemicarbazone derivatives, Int. J. Pharm. Sci. Nanotech. 1 (2009) 357-362.
42. H. P. Singh, C. S. Chauhan, S. N. Pandeya and C. S. Sharma, Chalcone semicarbazone: a new scaffold for antiepileptic drug discovery, J. Chil. Chem. Soc. 55 (2010) 103-106; DOI: 10.4067/50717-970720 10000 100024.
43. H. P. Singh, S. N. Pandeya, C. S. Chauhan and C. S. Sharma, Synthesis and pharmacological screening of some novel chalconyl derivatives of substituted phenylsemicarbazide, Med. Chem. Res.; DOI: 1007/S00044-000-9277-6.
44. H. P. Singh, C. S. Chauhan, S. N. Pandeya, C. S. Sharma, B. Srivastava and M. Singhal, Synthesis and pharmacological screening of some novel chloro chalcone semicarbazone derivatives, Pharm. Chem. 2 (2010) 343-357.
45. S. N. Pandeya, A. K. Agrawal, A. Singh and J. P. Stables, Design and synthesis of semicarbazones and their sioisosteric analogues as potent anticonvulsant: The role of hydrogen bonding, Acta Pharm. 53 (2003) 15-24. (Pubitemid 36514231)
46. P. Yogeeswari, D. Sriram, S. N. Pandeya and J. P. Stables, 4-Sulphamoyl semicarbazones with anticonvulsant activity, Farmaco 59 (2004) 609-613; DOI: 10.1016/j.farmac.2004.01.009.
47. R. Thirumurugan, D. Sriram, A. Saxena, J. P. Stables and P. Yogeeswari, 2, 4-Dimethoxy phenylsemicarbazones with anticonvulsant activity against three animal models of seizures. Synthesis and pharmacological evaluation, Bioorg. Med. Chem. 9 (2006) 3106-3112.
48. P. Yogeeswari, R. Thirumurugan, R. Kavya, J. S. Samuel and J. P. Stables, 3-Chloro-2-methyl phenyl substituted semicarbazones: Synthesis and anticonvulsant activity, Eur. J. Med. Chem. 39 (2004) 729-734. (Pubitemid 38970087)
49. P. Yogeeswari, D. Sriram, V. Veena, R. Kavya, R. Rakhra, J. V. Raghvendran, S. Mehta, R. Thirumurugan and J. P. Stables, Synthesis of arylsemicarbazones as potential anticonvulsants agents, Biomed. Pharmacother. 59 (2005) 57-55; DOI: 10.1016/j.biopha 2004.04.013.
50. S. N. Pandeya, I. Ponnilavarasan, A. Pandey, R. Lakhan and J. P. Stables, Evaluation of p-nitrophenyl substituted semicarbazones for anticonvulsant properties, Pharmazie 54 (1999) 923-925.
51. N. Aggarwal, P. Mishra, B. P. Nagori, R. Aggrawal and J. Jain, Anticonvulsant and neurotoxicity evaluation of some N(4)-phenylsubstituted pyridyl semicarbazones, CNS Agents Med. Chem. 9 (2009) 245-249; DOI: 10.1016/j.ejps 2003.08.002.
52. A. S. Raja, S. N. Pandeya, S. S. Panda and J. P. Stables, Synthesis and anticonvulsant evaluation of semicarbazones of acetophenone Mannich bases, Pharm. Chem. J. 41 (2007) 302-307. (Pubitemid 350172141)
53. S. Mehta, P. Yogeeswari, D. Sriram and S. Induja, Microwave-assisted synthesis, anticonvulsant activity and quantum mechanical modeling of N-(4-bromo-3-methyl phenyl) semicarbazones, J. Zhegiang. Univ. Sec. B, 8 (2007) 45-55; DOI: 10.1631/ZUS 2007.B0045.
54. S. Mehta, P. Yogeeswari, D. Sriram, P. Kendyer, P. R. Kumar, S. Induja and J. P. Stables, Quantum mechanical modelling of N4-(2, 5-disubstituted phenyl) semicarbazones: Synthesis and anticonvulsant activity of N4-(2, 5-dimethyl phyenyl/2-fluoro-5-methyl phenyl) semicarbazones, Med. Chem. 2 (2006) 617-625. (Pubitemid 44741617)
55. P. Yogeeswari, D. Sriram, R. Thirumurugan, J. V. Ragvendran, K. Sudhansu and J. P. Stables, Discovery of N-[2, 6-dimethylphenyl) substituted semicarbazones as anticonvulsant effective against various animal model of seizures with GABA-T-inhibitory activity, J. Med. Chem. 48 (2005) 6202-6211; DOI: 10.1021/jm050283b.
56. F. Azam, T. A. Alkaskas, S. L. Khokra and O. Prakash, Synthesis of novel N1-(naphtha[1, 2-d] thiazol-2-yl) semicarbazides as potential anticonvulsant, Eur. J. Med. Chem. 44 (2009) 203-211.
57. N. Siddiqui, A. Rana, S. A. Khan, M. A. Bhat and S. E. Haque, Synthesis of benzthiazole semicarbazones as novel anticonvulsant. The role of hydrophobic domain, Bioorg. Med. Chem. Lett. 17 (2007) 4178-4182; DOI: 10.1002/ardp. 200800130. (Pubitemid 47021404)
58. S. Mehta, R. K. Pavana, P. Yogeeswari, D. Sriram, J. P. Stables, Heteroaryl-substituted semicarbazones. Synthesis and anticonvulsant activity of N-(3-methyl pyridine-2-yl)-substituted semicarbazones, J. Heter. Chem. 43 (2009) 1287-1293; DOI: 10.1002/jRet 5570430522. (Pubitemid 44736295)
59. N. Aggarwal and P. Mishra, Synthesis and evaluation of 4-substituted Semicarbazones of levulinic acid for anticonvulsant activity, J Zhejiang Univ. Sci. B. 6 (2005) 617-621; DOI: 10. 1631/jZUS. 2005.B0617. (Pubitemid 41037812)
60. M. Taroua, C. Ribuot, M. H. Pera, G. Tailandier, M. Fatome, J. D. Laval, P. Demengec and G. Leclerc, New -and-semicarbazone and thiosemicarbazone 1, 3-dithiolones as radioprotectors anticonvulsant activity, Eur. J. Med. Chem. 31 (1996) 589-595; DOI: 10.1002chin.1996 461 40. (Pubitemid 26283969)
61. H. Rajak, R. Deshmukh, N. Aggarwal, S. Kashaw, M. D. Kharya and P. Mishra, Synthesis of novel 2, 5-disubstituted-1, 3, 4-thiadiazoles for their potential anticonvulsant activity: Pharmacophoric model studies, Arch. Pharm. Pharm. Med. Chem. (Weinheim) 342 (2009) 453-461.
62. N. Siddiqui, M. F. Arshad and S. A. Khan, Synthesis of some new coumarin incorporated thiazoylsemicarbazones as anticonvulsants, Acta Pol. Pharm. 66 (2009) 161-167.
63. I. Ponnilavarasan, S. Ganguly and V. Pandit, Design and synthesis of novel quinazolinone derivatives as broad spectrum anticonvulsants and antimicrobial agents, J. Pharm. Res. 3 (2010) 703-706.
64. J. R. Dimmock and G. B. Baker, Anticonvulsant activities of 4-bromobenzaldehyde semicarbazones, Epilepsia 35 (1994) 648-655; DOI: 10.1111/j.1528-1157.1994.tb02486x.
65. S. N. Pandeya, H. Manjula and J. P. Stables, Design of semicarbazones and their bio-isosteric analogues as potential anticonvulsants, Pharmazie 56 (2001) 121-124. (Pubitemid 32167200)
66. S. N. Pandeya, B. N. Singh and J. Mishra, Synthesis and biological activity of substituted arylsemicarbazones, Acta Sci. Ind. XXXIIIC (2007) 85-92.
67. S. N. Pandeya, S. Smitha and J. P. Stables, Anticonvulsant and sedative-hypnotic activities of N-substituted isatin semicarbazones, Arch. Pharm. (Weinheim) Pharm. Med. Chem. 4 (2002) 129-134; DOI: 10.1002/1521- 4184(200204). (Pubitemid 34728740)
68. S. N. Pandeya, S. Kohli, N. Siddiqui and J. P. Stables, Synthesis and anticonvulsant activities of 4-N-substituted arylsemicarbazones, Pol. J. Pharmacol. 55 (2003) 565-571. (Pubitemid 37185360)
69. S. N. Pandeya, A. S. Raja and J. P. Stables, Synthesis of isatin semicarbazones as novel anticonvulsant role of hydrogen bonding, J. Pharm. Pharm. Sci. 5 (2002) 266-271. (Pubitemid 37207253)
70. A. Singh, C. Pande, P. Gahtori, S. N. Pandeya and J. P. Stables, Design and synthesis of some novel 4(4-substituted aryl) semicarbazones as anticonvulsant agents, Indian J. Pharm. Sci. 72 (2010) 363-367; DOI: 10.4103 10250-474x70485.
71. N. Aggarwal and P. Mishra, Synthesis of 4-arylsubstituted semicarbazones of some terpenes as novel anticonvulsants, J. Pharm. Pharm. Sci. 7 (2004) 260-264. (Pubitemid 41528900)
72. N. Aggrawal, R. Aggarwal, P. Mishra, J. S. Jain, S. K. Bansal and K. K. Jha, Design and evaluation of semicarbazones and thiosemicarbazones as novel anticonvulsants, CNS Agents Med. Chem. 8 (2008) 26-28. (Pubitemid 351468879)
73. J. R. Dimmock, K. K. Sidhu, R. S. Thayer, P. Mack, M. J. Duffy, R. S. Reid, J. W. Quail, U. Pugazhenthi, A. Ong, J. A. Bikker and D. F. Weaver, Anticonvulsant activities of some arylsemicarbazones, displaying potent oral activity in the maximal electroshock screen in rats acconpanied by high protective indices, J. Med. Chem. 36 (1993) 2243-2265; DOI: 10.1021/jm000689001.
74. J. R. Dimmock, K. K. Sidhu, S. D. Thumber, S. D. Basram, M. Chen, J. W. Quail, J. Yang, I. Rozas and D. F. Weaver, Some arylsemicarbazones possessing anticonvulsant activity, Eur. J. Med. Chem. 30 (1995) 287-301.
75. J. R. Dimmock, R. N. Puthucode, J. M. Smith, M. Hetherington, J. W. Quail, U. Pugazhenthi, R. Lecher and J. P. Stables, (Aryloxy) aryl semicarbazones and related compounds: A novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen, J. Med. Chem. 39 (1996) 3984-3997; DOI: 10.1021/jm9603025. (Pubitemid 26327435)
76. R. N. Puthucode, U. Pugazenthi, J. W. Quail, J. P. Stables and J. R. Dimmock, Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones, Eur. J. Med. Chem. 33 (1998) 595-607.
77. J. R. Dimmock, H. A. Semple, S. John, M. A. Beazely and G. D. Abrams, Isolation and identification of the major urinary metabolite of 4-(4-fluorophenoxy)benzaldehyde semicarbazones after oral dosing to rats, Pharmazie 54 (1999) 260-262. (Pubitemid 29296992)
78. K. Ramu, G. N. Lam and H. Huges, In vivo metabolism and mass balance of 4[4-fluorophenylbenzaldehyde semicarbazone (CO102862) in rats, Drug Metab. Dispos. 28 (2000) 1153-1161.
79. K. Ramu, G. N. Lam and B. Chin, Development of a high-performance liquid chromatorgraphy tandem mass spectrum of the method for the determination of pharmacokinetic of C0102802 in mouse, rat, monkey and dogs plasma, J. Chromatogr. 741 (2000) 1-15.
80. N. C. Lam, Sodium channel blocker compositions and the use thereof, Pat. W0 00/6 11 88, 19 Oct. 2000.
81. N. Micale, M. Zappala, S. Grazzo, G. Puja, G. Desarro, G. Ferreri, A. Desarro, L. Toma and C. Di Michali, Novel potent AMP/Kainate receptor antagonists: Synthesis and anticonvulsant activity of series of 2[(4-alkyl semicarbazono)-(4-aminophenyl) methyl)-4, 5-methylene dioxy phenylacetic acid alkyl esters, J. Med. Chem. 45 (2002) 4433-4442.
82. N. Siddiqui, M. S. Alam and W. Ahsan, Synthesis, Anticonvulsant and toxicity evaluation of 2(1H-indol-3yl)acetyl-N-substituted phenyl) hydrazine carbothioamides and their related heterocyclic derivatives, Acta Pharm. 58 (2008) 445-459; DOI: 10.2478/v1007-008-0025-0.5.
83. S. Mehta, P. Yogeeswari, D. Sriram and J. P. Stables, Cyclization of the semicarbzone template of arylsemicarbazones: Synthesis and anticonvulsant activity of 4, 5-(diphenyl)-2H-1, 2, 4-triazole-3-(4H)-one, Biomed. Pharmacother. 63 (2009) 187-193; DOI: 10.1016/j.biopha.2006.04.002.
84. P. Czapinski, B. Blaszezyk and S. J. Czuczwar, Mechanism of action of antiepileptic drugs, Curr. Top. Med. Chem. 5 (2005) 3-14.
85. V. I. Ilyin, D. D. Hodges, E. R. Whitmore, R. B. Carter, S. X. Cai and R. M. Woodward, V102862 (CO102862): A potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels, Br. J. Pharmacol. 144 (2005) 801-812; DOI: 10.1038/sj.bjp.0706058. (Pubitemid 40520506)
86. P. Yogeeswari, D. Sriram, A. Brahmanandan, I. Sridharan, R. Thirumurugan and J. P. Stables, Synthesis of novel arylsemicarbazones as anticonvulsants with GABA-mediated mechanism, Med. Chem. Res. 12 (2003) 57-68. (Pubitemid 37544021)
87. W. E. Stone and M. J. Javid, Quantititative evaluation of the action of anticonvulsants against different chemical convulsants, Arch. Int. Pharmacodyn. Ther. 240 (1979) 66-78. (Pubitemid 9240708)
88. W. E. Stone and M. J. Javid, Anticonvulsant and convulsive effects of lidocaine: Comparison with those of phenytoin, and implication for mechanism of action concepts, Neurol. Res. 10 (1988) 161-168.
89. R. L. McDonald and K. M. Kelly, Antiepileptic drug mechanism of action, Epilepsia 36 (Suppl. 2S) (1995) 2-12.
90. P. Yogeeswari, J. V. Ragavendran, D. Sriram, V. Nageswari, R. Kavya, N. Srivastsan, K. Vanitha and J. P. Stables, Discovery of 4-aminobutyric acid derivatives possessing anticonvulsant and antinociceptive activities: a hybrid pharmacophore approach, J. Med. Chem. 50 (2007) 2459-2467; DOI: 10.1021/jm061431g. (Pubitemid 46799258)
91. B. Malawaska and A. Scatturin, Application of pharmacophore models for the design and synthesis of new anticonvulsant drugs, Mini Rev. Med. Chem. 3 (2003) 341-348.
92. J. Riss, J. Cloyd, J. Gates and S. Collins, Benzodiazepines in epilepsy pharmacology and pharmacokinetics, Acta Neurol. Scand. 118 (2008) 64-86; DOI: 10.1111/j.1600-0404.2008.01004.x.